Genesco's top two sell $1.4M of stock

Genesco's leading executives continued to trim their stakes in the company this week. On Tuesday and Wednesday, Chairman, President and CEO Bob Dennis sold $1.1 million worth of shares — a week after booking $2 million in profit on an options exercise — in a deal that still leaves him with about $16 million of Genesco stock. On the same days, CFO Jim Gulmi sold about 3 percent of his shares for roughly $320,000. Shares of Genesco (Ticker: GCO) are up slightly so far in 2014.

On a smaller scale, Clarcor director Philip Lochner on Wednesday exercised 7,500 stock options that would have expired in three years and then sold the resulting shares. His profit on the transactions was almost $190,000. Clarcor shares (Ticker: CLC) are down about 12 percent year to date.

These transactions were the latest in a series of noteworthy insider trades by local executives over the past few months. By our rough count, those deals have generated gains of about $35 million.

Mar 28, 2014 7:17 AM

Clarcor investors vote down sustainability reporting measure

Boston firm had argued for global report
Mar 27, 2014 7:34 AM

Clarcor's Q1 up slightly

Recent GE acquisition does well but impact expected to abate
Mar 20, 2014 2:24 PM

Clarcor board fights sustainability reporting push

Boston investment firm says tracking efforts would 'more readily identify issues affecting the overall business'
Feb 26, 2014 7:38 AM

Local companies get slew of new 5% owners

Two big names disclose stakes in Brookdale; others have been buying Kirkland's, Healthcare Realty and Clarcor
Feb 12, 2014 7:03 AM

Investment manager adds a little to Clarcor stake

Storied Boston investment firm Eaton Vance in 2013 added a little bit to its holdings of Franklin-based Clarcor. This week, the firm filed papers showing that it controlled 6.15 percent of the filtration and packaging manufacturer as of Dec. 31. Eaton Vance, which manages more than $280 billion, held about 5.8 percent of Clarcor's stock a year ago.

Jan 28, 2014 8:39 AM

Analyst action: Clarcor, Healthcare Realty

Richard Eastman at Robert W. Baird says investors should take a more cautious stance on Clarcor following the Franklin-based filtration company's earnings report. He has cut his rating to 'neutral' from 'outperform' and trimmed his price target to $59 from $62. Clarcor (Ticker: CLC) was changing hands at $58.40 in early Friday trading.

Analysts at JPMorgan have similarly lowered their opinion of Healthcare Realty Trust to 'neutral' from 'overweight' and taken down their target to $23 from $26. Shares of Healthcare Realty (Ticker: HR) were down slightly at $22.32 this morning. They've fallen about 8 percent in the past three months.

Jan 17, 2014 10:28 AM

Earnings wrap: Clarcor

Filtration and packaging manufacturer Clarcor reported fourth-quarter profits of $32.9 million, down 10 percent from its year-prior results, as gross margins slipped on slightly higher revenues. Clarcor's EPS of 65 cents was 5 cents below analysts' expectations but includes $2.7 million, or 4 cents per share, in costs related to the company's recent GE and Bekaert acquisitions. CEO Chris Conway and his team also released early 2014 EPS guidance of $2.55 to $2.70, below the Street's $2.73.

Jan 16, 2014 7:04 AM

Another acquisition for Clarcor

Franklin company pays $8M for unit of Belgian conglomerate
Dec 4, 2013 6:44 AM

Clarcor buying GE turbine filter business

Deal for unit with plants in US, UK, China adding $230M in revenues
Nov 5, 2013 7:13 AM